ANGLE (LON:AGL) Trading Down 3.7% – Time to Sell?

ANGLE plc (LON:AGL)’s share price dropped 3.7% on Wednesday . The company traded as low as GBX 10.56 ($0.13) and last traded at GBX 10.84 ($0.14). Approximately 67,808 shares were traded during mid-day trading, a decline of 97% from the average daily volume of 2,012,045 shares. The stock had previously closed at GBX 11.25 ($0.14).

Analyst Ratings Changes

Separately, Berenberg Bank reissued a “buy” rating and set a GBX 70 ($0.88) target price on shares of ANGLE in a research report on Thursday, September 26th.

ANGLE Stock Performance

The company has a current ratio of 5.19, a quick ratio of 6.18 and a debt-to-equity ratio of 17.22. The firm has a market cap of £35.48 million, a PE ratio of -157.14 and a beta of 0.22. The stock’s 50 day moving average price is GBX 9.15 and its 200 day moving average price is GBX 12.10.

ANGLE Company Profile

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.